Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/PHAXIAM-THERAPEUTICS-S-A-13046812/actualite/Erytech-Goldman-Sachs-Group-passe-les-5-du-capital-et-DDV-37425988/?utm_source=whatsapp&utm_medium=social&utm_campaign=share